Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 18 pseudogene 68 (KRT18P68) is classified as a pseudogene—an inactivated genomic sequence that shares homology with the functional keratin 18 gene (KRT18) but does not code for a functional protein. The canonical, protein-coding gene in the region is KRT18, which encodes a structural intermediate filament protein expressed in simple epithelial tissues and is widely studied for its roles in tissue structure, epithelial tumor diagnosis, and cell regulation[1][2][3][4]. However, KRT18P68 itself lacks evidence for a coding, functional, or therapeutic role and does not participate in biological pathways, nor are there associated drugs or disease roles reported in biomedical or pharmacological sources. Is there something wrong with this target? Yes, referring to "KRT18P68" in the context of a therapeutic target or functional receptor is incorrect, as it is a **pseudogene** and current evidence does not suggest it functions at a protein or RNA level relevant to molecular targeting in medicine or biology. The functional gene of importance is "Keratin 18" (KRT18), not "KRT18P68." As such, queries or analyses expecting structure/function, pharmacology, or disease links relate to the functional KRT18, not this pseudogene. Summary of context: - Functional and clinical roles—such as those in tumor diagnosis, apoptosis regulation, and cytoskeletal structure—are attributed to **Keratin 18 (KRT18)**, not KRT18P68[1][2][3][4]. - Pseudogenes like KRT18P68 generally do not encode protein and are not established molecular drug targets. - No drugs, mechanisms, biomarkers, or disease associations are recorded for KRT18P68 in research or clinical databases. If you intended the functional **Keratin 18** target, please specify "Keratin 18 (KRT18)." Conversely, if your search is specifically about the pseudogene KRT18P68, it should be excluded from most structured target databases as a non-target entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 18 pseudogene 68 (KRT18P68).